Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Cisplatin Injection
Status: Currently in Shortage
»Date first posted:
02/10/2023
»Therapeutic Categories: Oncology; Pediatric
Accord Healthcare Inc. (Reverified 04/17/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 1 mg/1 mL (NDC 16729-288-11) | Available | Stock Available; Inventory shipping to orders | |
| Injection, 1 mg/1 mL (NDC 16729-288-38) | Available | Stock Available; Inventory shipping to orders | |
| Injection, 1 mg/1 mL (NDC 68001-283-27) | Unavailable | Marketed by BluePoint Laboratories. SKU is Make-to-Order and there currently is zero demand. | Requirements related to complying with good manufacturing practices |
| Injection, 1 mg/1 mL (NDC 68001-283-32) | Unavailable | Marketed by BluePoint Laboratories. SKU is Make-to-Order and there currently is zero demand. | Requirements related to complying with good manufacturing practices |
Fresenius Kabi USA, LLC (Reverified 04/16/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 1 mg/1 mL (NDC 63323-103-51) | Available | Check wholesaler for inventory | |
| Injection, 1 mg/1 mL (NDC 63323-103-65) | Available | Check wholesaler for inventory | |
| Injection, 1 mg/1 mL (NDC 63323-103-64) | Available | Check wholesaler for inventory |
Gland Pharma Limited (Revised 03/15/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Cisplatin, Injection, 1 mg/1 mL (NDC 25021-253-50) | Unavailable | Marketed by Sagent. | Demand increase for the drug |
| Cisplatin, Injection, 1 mg/1 mL (NDC 25021-253-51) | Available | Available on allocation; Marketed by Sagent. | Demand increase for the drug |
Hikma Pharmaceuticals USA, Inc. (Reverified 04/16/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 1 mg/1 mL (NDC 0143-9504-01) | Available | Additional lots will be available. Product will be made available as it is released. | |
| Injection, 1 mg/1 mL (NDC 0143-9505-01) | Unavailable | Additional lots will be available in the April - May 2024 timeframe. Product will be made available as it is released. | Demand increase for the drug |
HQ Specialty Pharma (Reverified 04/15/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 1 mg/1 mL (NDC 44567-511-01) | Available | Marketed by WG Critical Care | |
| Injection, 1 mg/1 mL (NDC 44567-530-01) | Available | Marketed by WG Critical Care |
Qilu Pharmaceutical Co., Ltd. (Revised 01/15/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 50 mg/50 mL (NDC 60505-6277-0) | Product is currently available with one additional batch to be available late February 2024. | Qilu Pharmaceutical Co., Ltd., in coordination with the U.S. FDA and Apotex Corp., has initiated temporary importation of CISplatin Injection 50 mg/50 mL (1 mg/mL) vials into the U.S. market to address a drug shortage of CISplatin. Product is available via Apotex Corp.'s authorized distributors. Contact your primary wholesaler/distributor to place orders. | Demand increase for the drug |
Teva Pharmaceuticals USA, Inc. (Revised 02/06/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Cisplatin Injection, Injection, 50 mg/50 mL (NDC 0703-5747-11) | Allocating existing supplies | ||
| Cisplatin Injection, Injection, 100 mg/100 mL (NDC 0703-5748-11) | Allocating existing supplies |